N-(Pyrazin-2-ylcarbonyl)glycine
CAS: 57229-37-5
Ref. 3D-HCA22937
| 1g | To inquire | ||
| 5g | To inquire | ||
| 100mg | To inquire | ||
| 250mg | To inquire | ||
| 500mg | To inquire |
Product Information
N-(Pyrazin-2-ylcarbonyl)glycine (PZAG) is a prodrug that is converted to pyrazinoic acid in vivo. It is an inhibitor of HIV protease and has been shown to have a pharmacokinetic profile suitable for once-daily administration. PZAG has also been shown to inhibit the production of uric acid, which may be due to its ability to inhibit deamidases that produce uric acid from purines. PZAG may interact with other drugs, such as antibiotics, which are involved in the elimination phase of drug metabolism.
Chemical properties
Technical inquiry about: 3D-HCA22937 N-(Pyrazin-2-ylcarbonyl)glycine
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
